A1M Pharma a1m.se


Public lists: Pharma Startups (4733)

A1M Pharma is a biotechnology company that develops and commercializes medical applications based on the endogenous protein A1M. The company's current main focus is kidney protection in connection with Peptide Receptor Radionuclide Therapy (PRRT) – a targeted radiation therapy for cancer – and pre-eclampsia, a potentially fatal condition that affects around ten million pregnant women each year. A1M Pharma is headquartered in Lund, Sweden.

A1M Pharma is a biotechnology company that develops and commercializes medical applications based on the endogenous protein A1M. The company's current main focus is kidney protection in connection with Peptide Receptor Radionuclide Therapy (PRRT) –...Show all

Company (IPO / Went public)

Phone:

Fax:

Scheelevägen 22

Lund, SE-223 63
Sweden

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
A1M Pharma $0M Jun 20, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related A1M Pharma Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Diagnosis and treatment of preeclampsia Feb 12, 2008 Oct 29, 2013 Patent
Biomarkers for preeclampsia Mar 16, 2016 Application
Diagnosis and treatment of preeclampsia Sep 17, 2013 Application
Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases Sep 04, 2013 Application